Table 1 Baseline characteristics of participants
From: Oral sodium bicarbonate in people on haemodialysis: a randomised controlled trial
Control (N = 20) | Intervention (N = 16) | p-value | |
|---|---|---|---|
Age | 58 (52-67) | 57 (49-63) | 0.18 |
Gender (male) | 15 (75%) | 12 (75%) | 0.87 |
Ethnicity | 0.26 | ||
White | 8 (40%) | 4 (25%) | |
Black African / Caribbean | 4 (20%) | 5 (31%) | |
Asian / Other | 8 (40%) | 7 (44%) | |
Cause of renal disease | 0.79 | ||
Diabetes | 7 (35%) | 5 (31%) | |
Nephritis | 6 (30%) | 3 (19%) | |
Hereditary | 1 (5%) | 2 (12%) | |
Other | 6 (30%) | 6 (37%) | |
Diabetes | 9 (45%) | 6 (38%) | 0.83 |
Haemodialysis vintage (months) | 38 (23-83) | 23 (10-51) | 0.14 |
Kt/V | 1.6 (0.3) | 1.44 (0.6) | 0.65 |